Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	46.52B
Revenue (ttm)	18.60B
Net Income (ttm)	1.45B
Shares Out	1.37B
EPS (ttm)	1.06
PE Ratio	32.06
Forward PE	32.15
Dividend	1.00 (2.94%)
Ex-Dividend Date	Jun 30, 2025

Volume	6,347,977
Average Volume	7,683,831
Open	34.02
Previous Close	34.02
Day's Range	33.86 - 34.12
52-Week Range	33.30 - 44.26
Beta	0.15
RSI	36.80
Earnings Date	Oct 31, 2025

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the research, production, distribution, and sale of Chinese patent medicines in China and internationally. It operates through the Company, Science Company, Commerce Company, and Others segments. The company offers various product dosage forms, such as pills, powders, alcoholic preparations, capsules, oral liquids, and dripping pills. Its products are used for cardiovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive system, pediatrics, wind and dampness-removing, or...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,883
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2024, Beijing Tongrentang's revenue was 18.60 billion, an increase of 4.12% compared to the previous year's 17.86 billion. Earnings were 1.53 billion, a decrease of -8.54%.